SCHEMBL13619926

SCHEMBL13619926

N#Cc1ccc(N(c2ccccc2)/[N+]([O-])=N/O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42
KMT2A Q03164 2/20 0.39
NPC1 O15118 2/20 0.39
MEN1 O00255 1/20 0.39
MAOB P27338 3/20 0.38
MAOA P21397 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
SNCA P37840 1/20 0.37
CA2 P00918 3/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA6 P23280 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA1 P00915 2/20 0.34
FBP1 P09467 3/20 0.34
CTBP2 P56545 1/20 0.34
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13619925 0.84 CA1 (0.45) KMT2ANPC1MEN1CA2CA1
SCHEMBL13619903 0.84 ALDH1A1 (0.43) KMT2ANPC1MEN1CRHBPCRHR2
SCHEMBL16727260 0.78 MMP2 (0.36) KMT2AMEN1CA2CA9CA1
SCHEMBL13619909 0.76 FBP1 (0.39) KMT2AMEN1CA2CA12CA3
SCHEMBL13619927 0.73 NR1H3 (0.41) KMT2AMEN1CA2CA12CA3
SCHEMBL13619910 0.72 FBP1 (0.36) CA2CA12CA3CA6CA9
SCHEMBL13619912 0.72 FBP1 (0.36) KMT2AMEN1CA2CA12CA3
SCHEMBL13619915 0.72 KEAP1 (0.41) KMT2ANPC1MEN1MAOBSNCA
SCHEMBL151680 0.72 TSHR (0.59) TSHRKMT2ANPC1MEN1MAOB
SCHEMBL13748419 0.72 TSHR (0.59) TSHRKMT2ANPC1MEN1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141378-A1 NITROXYL PROGENITOR COMPOUNDS AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-05-21 US disclosed
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use THE JOHN HOPKINS UNIVERSITY (US) 2009-11-12 US disclosed
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use THE JOHN HOPKINS UNIVERSITY (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use HMOX2, NNMT, HMOX1 TSHR 4834/4885KMT2A 1272/4885NPC1 726/4885
US-20150141378-A1 NITROXYL PROGENITOR COMPOUNDS AND METHODS OF USE HMOX2, NNMT, HMOX1 TSHR 4834/4885KMT2A 1272/4885NPC1 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.